SANTA BARBARA, Calif., Feb. 09, 2016 -- AppFolio, Inc. (NASDAQ:APPF), today announced that it will present at two upcoming conferences.
AppFolio will present at the Morgan Stanley Technology, Media and Telecom Conference on Tuesday, March 1, 2016 at The Palace Hotel in San Francisco.
In addition, the Company will present at the Pacific Crest 11th Annual Emerging Technology Summit on Wednesday March 2, 2016 which is being held at The Park Central Hotel in San Francisco.
About AppFolio
AppFolio provides comprehensive, easy-to-use, cloud-based business software solutions for small and medium-sized businesses in various vertical markets. Our products include cloud-based property management software (AppFolio Property Manager) and cloud-based legal practice management software (MyCase). The company was founded in 2006 and is headquartered in Santa Barbara, CA. Learn more at www.appfolioinc.com.
CONTACT: Investor Relations: Erica Abrams, [email protected], 805.364.6093


Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



